MRD / Regn No. : 20260000305 Date : 17/06/2026
Patient Name : Ramanan Mahadevan Age & Gender : 78 Yrs. / Male
Contact No. : 9380408052 UHID :
Ht / Wt / BMI : 163 / 81 / 30.49 BP S / BP D : 140 / 70
Allergies : NKA Referred By :
   
Subjective : DM FOR 15 YEARS,CABG IN 1996,THYROID DYSFUNCTION FOR 3 YEARS,ASTHMA FOR 1 YEAR,HAS STOPPED SEMAGLUTIDE
Objective : NAD
Analysis : HYPOTHYROIDISM,ATHEROSCLEROTIC CARDIOVASCULAR DISEASE,TYPE 2 DM,LOSS OF PROTECTIIVE SENSATION,DR CHANGES IN THE FUNDUS
Plan : INCREASE OBEDA TO 0.5 MG,SEE ME IN 1 MONTH  
Salient Investigations : FASTING PLASMA GLUCOSE (FPG): 175 mg/dL | GLYCOSYLATED HEMOGLOBIN (HBA1C): 7.9 % | POST PRANDIAL GLUCOSE (2HPP): 284 mg/dL
S# Generic (Trade) Name Route Dosage Usage Duration
1 INJECTION DEGLUDEC / ASPART (INJ U100) 70/30
RYZODEG
Medicine For DIABETES
SQ 16-0-12 UNITS BEFORE FOOD
TILL NEXT VISIT
MAY CAUSE HYPOGLYCEMIA
2 SGLT2I EMPAGLIFLOZIN 10 MG
JARDIANCE
Medicine For DIABETES OBESITY HEART AND KIDNEY PROTECTION
PO 1-0-0 BEFORE FOOD
TILL NEXT VISIT
MAY CAUSE GENITOURINARY INFECTIONS
3 INJECTION SEMAGLUTIDE
OBEDA 0.5 MG
Medicine For DIABETES OBESITY HEART AND KIDNEY PROTECTION
SQ ONCE A WEEK AS DIRECTED NO RELATION TO FOOD
MAY CAUSE NAUSEA VOMITING OR VISUAL DISTURBANCE
       
Refill : 0 / Substitution:    
Education :
Next Visit : 17/Jul/2026
Tests Suggested For Next Visit : FBS 2HPP SMBG
   
   

Dr. Krishna G Seshadri
Sr. Consultant Endocrinology Diabetes and Metabolism
Tamil Nadu / 48748 HPRID: 71-0638-2075-7542

This is a Computer generated Prescription

Powered By: